The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks long-term capital appreciation.
The fund normally invests at least 80% of its total assets in a diversified portfolio of equity securities, or derivative investments that provide exposure to equity securities, of companies located outside of the United States that the fund's sub-advisers consider to offer attractive valuations. It invests in a variety of countries throughout the world including emerging market countries and may, from time to time, invest more than 25% of its assets in any one country or group of countries. The fund may invest in companies of any market capitalization.
The average market capitalization across the Hartford Schroders Intl Multi-Cp Val SDR MF is 124.89B. The market cap for tickers in the group ranges from 3.51M to 212.85B. SHEL holds the highest valuation in this group at 212.85B. The lowest valued company is NOVN at 3.51M.
The average weekly volume growth across all stocks in the Hartford Schroders Intl Multi-Cp Val SDR MF was -2%. For the same stocks of the MF, the average monthly volume growth was 25% and the average quarterly volume growth was 39%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 48
P/E Growth Rating: 49
Price Growth Rating: 51
SMR Rating: 54
Profit Risk Rating: 65
Seasonality Score: 9 (-100 ... +100)